Latest News

AQST DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action – AQST

ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - SES

BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting

ROSEN, LEADING INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Silicon Valley 101 and Power HF Host AI Infrastructure Forum, Spotlighting Power as the Next Battleground

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX

Pomerantz LLP Reminds Shareholders with Losses on their Investment in Gartner, Inc. – IT

ROSEN, A LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

Pomerantz LLP Updates Shareholders on Legal Action Brought Against Trip.com Group Limited – TCOM

Pomerantz LLP Issues Important Reminder to Vital Farms, Inc. Investors – VITL